Background-Chronic inflammation and oxidative stress are thought to be involved in colorectal cancer (CRC) development. These processes may be contributed to by leakage of bacterial products, such as lipopolysaccharide (LPS) and flagellin, across the gut barrier. The objective of this study, nested within a prospective cohort, was to examine associations between circulating LPS and flagellin serum antibody levels and CRC risk.
Introduction
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and a leading cause of death worldwide (1) . It has been postulated that dietary and metabolic factors, such as energy excess and obesity, can cause breakdown of the colonic epithelial barrier function, allowing the interaction of these receptors with bacterial products such as lipopolysaccharide (LPS), also known as endotoxin (2) . The human gastrointestinal (GI) tract is colonized by a complex community of approximately 10 14 commensal bacteria, representing approximately 1,000 species (3) . Colonic microbiota are being increasingly recognized as important contributors to GI health and likely also to CRC development (4) .
LPS is an integral part of the outer membrane of Gram-negative bacterial cell wall and also has a major role in both acute and chronic inflammation (11) . A related bacterial product is flagellin, the primary structural component of flagella and a dominant target of humoral immunity in response to infection (12) . Emerging evidence suggests that an overabundance of bacterial LPS from the gut microbiota may trigger chronic inflammation and increased production of pro-inflammatory cytokines and increased reactive oxygen species (2, 13) . These pro-inflammatory cytokines can activate the nuclear factor κβ (NF-κβ) pathway, which has been implicated in cell proliferation and DNA damage leading to carcinogenesis (14) . Chronic inflammation has been associated with increased risk of CRC by several studies (15) . Thus, hypothetically, long term exposure to the localized inflammatory responses resulting from LPS exposure may promote CRC development.
Direct in vivo measurement of LPS and flagellin levels is challenging, in part because their appearance in blood and organs is sporadic and partly because their presence is quite transient. Hence, a few recent studies have measured levels of immunoglobulins against LPS and flagellin, whose levels can persist for months following exposure to these products, in an attempt to broadly assess systemic exposure to these gut microbial products and probe their potential associations with various disease states (16, 17) . In a recent study by Ziegler et al. (16) , flagellin-and LPS-specific serum immunoglobulin levels (IgM, IgA, and IgG) were markedly increased in patients with short bowel syndrome (SBS) compared with healthy controls. In another study, IgA and IgG antibodies specific for flagellin monomers were shown to be a target of the elevated adaptive immune response associated with Crohn's disease, a chronic inflammatory disease of the GI tract (18) . Another line of evidence has emerged from a recent animal study which explored the intricate relationship between intestinal barrier function, microbial environment and inflammation in CRC by demonstrating that an inflammatory microenvironment promotes CRC progression in mice (19) . The study highlighted that defective intestinal barrier function at tumour sites facilitates invasion of microbial products triggering inflammation and subsequent tumour growth.
While the role of microbiota in development of colorectal carcinogenesis has been explored in basic science and animal studies (19, 20) , there is currently no direct epidemiologic evidence for the role of endotoxemia and gut barrier dysfunction in CRC aetiology. In the present study, we aimed to examine the association between serum LPS-and flagellinspecific immunoglobulin levels (IgA, and IgG) and risk of CRC development within a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Methods and Materials

Study population and data collection
We used a case-control design nested within the EPIC cohort, a large prospective cohort study with over 520,000 subjects enrolled from 23 centres in 10 Western European countries (Denmark, France, Greece, Germany, Italy, Netherlands, Norway, Spain, Sweden, and United Kingdom). Details of the design and methods of the EPIC study, including information on dietary assessment methods, blood collection protocols, and follow-up procedures, have been previously described in detail (21). Briefly, individuals who were eligible for the study were selected from the general population of a specific geographical area, town, or province. Exceptions included the French sub-cohort, which is based on members of the health insurance system or state-school employees, and the Utrecht (Netherlands) sub-cohort, which is based on women who underwent screening for breast cancer. Between 1992 and 1998, standardized lifestyle and personal history questionnaires, anthropometric data and blood samples were collected from most participants at recruitment. Diet over the previous 12 months was assessed at recruitment by validated country-specific questionnaires designed to ensure high compliance and improved measures of local dietary habits (22).
In each of the study centres, fasting or non-fasting blood samples were drawn from participants who provided a blood sample and stored at 5°C to 10°C, protected from light, and transported to local laboratories for processing and aliquoting as previously described (21, 22) . In all countries, except Denmark and Sweden, blood was separated in the local EPIC centres and stored at the International Agency for Research on Cancer (Lyon, France; applied to wells coated with flagellin or LPS. After incubation and washing, the wells were incubated either with IgG coupled to horseradish peroxidase (GE, Catalog No. 375112) or, in the case of Ig-A-specific antibodies, with peroxidase-labeled IgA (KPL, Catolog No. 14-10-01). Quantitation of total immunoglobulins was performed using the colorimetric peroxidase substrate tetramethylbenzidine (TMZ), and optical density (OD) was read at 450 nm and 540 nm (the difference was taken to compensate for optical interference from the plate), with an ELISA plate reader. Data are reported as OD corrected by subtracting background (determined by readings in blank samples) and are normalized to each plate's control sample, which was prepared in bulk, aliquoted, frozen, and thawed daily as used. Only adjusted OD were used in the analysis. Standardization was performed using preparations of known concentrations of IgA and IgG. Because previously performed assays for these biomarkers in replicates had a very low intra-assay coefficient of variation (<5%) (23), our samples were analysed in singleton to minimize bio-sample volume requirement, cost and time. Inter-assay coefficients of variation were between 3.8% and 6.8%. For all analyses, cases and matched controls were run in the same batch, and the case-control status of the samples was blinded to laboratory technicians.
In the present study, secondary use was made of relevant biomarker measures that had been conducted previously on the same series of subjects (9, 24, 25) . Briefly, measurements of glycated haemoglobin (HbA1c) were done on erythrocyte hemolysate using high performance liquid chromatography method (Bio-Rad Variant II instrument, Bio Lad Labor atories, Hercules, California) with intra-batch coefficient of variations of 2.5% (24). Highsensitivity C-reactive protein (hs-CRP) concentrations were measured using a highsensitivity assay (Beckman-Coulter, Woerden, the Netherlands) on a Synchron LX-20 Pro autoanalayzer (Beckman-Coulter). The inter-assay coefficients of variation were 6.0% -6.5% at various concentrations of hs-CRP (25).
Statistical analysis
The distributions of selected characteristics between colon and rectal cases and the matched controls were compared. Normality of each biomarker was checked by visual inspection, and all were deemed to be approximately normal. Each individual biomarker, as well as, anti-flagellin (flagellin IgA + flagellin IgG), anti-LPS (LPS IgA + LPS IgG), and antiflagellin+LPS exposure (flagellin IgA + flagellin IgG + LPS IgA + LPS IgG) levels were categorized into quartiles based on the distribution among the controls with the lowest quartile as the reference category.
Conditional logistic regression was used to estimate the odds ratios (OR) and 95% confidence intervals (CI) of CRC, and by anatomical sub-site of cancers of colon and rectum in relation to levels of each circulating biomarkers. Risk estimates were computed from both univariate analyses adjusted for the matching factors (matching-adjusted), and multivariable analyses, with additional adjustments for established confounding variables (fully-adjusted), including smoking status (status/duration/intensity of smoking), body mass index (BMI, kg/m 2 ), waist circumference (cm), education level, total alcohol consumption (g/d), physical activity (sex-specific combined total physical activity index), total energy intake (kcal/day), and total daily intakes of fibre (g/day), fruits and vegetables (g/day), and red/processed meats (g/day) (26-31). For all models, collinearity was assessed and tests for linear trend were performed using a score variable with values from 1 to 4 included in the model, consistent with the quartile grouping.
We evaluated interactions by several factors relevant for CRC risk that may be also related to LPS-and flagellin-IgA and IgG concentrations, total bacterial load and/or to colonic barrier function (32). Sex and tumour location (colon, rectum) were proposed a priori as potential interactions so results are presented stratified by these factors, as well as combined. Other variables (i.e. alcohol intake, BMI, waist circumference, dietary fat, and hs-CRP) were studied for hypothesis generation analyses. Continuous analyses were conducted using a cross-product term of each biomarker and potential interaction term in the model, followed by a likelihood ratio test. Discrete analyses were also undertaken for BMI, waist circumference, dietary fat and hs-CRP by including an interaction term formed by the product of the total-antiflagellin+LPS tertile (cut-points: <5.58, 5.58 to < 7.19, ≥ 7.19) and the sex-specific dichotomized high and low categories of the potential interaction. As with continuous analysis, a likelihood ratio test was used to assess statistical significance.
As a sensitivity analysis, we repeated the main multivariable-adjusted models after excluding cases that occurred in the first 2 years of follow-up and their matched controls to avoid possible reverse causality, as well as after exclusion of countries with lowest (Denmark) and highest (Greece) LPS-and flagellin exposure levels.
Conditional logistic restricted cubic spline models were used to explore possible deviation from linear relationships between each biomarker and CRC, with 4 knots specific at the median of each quartile of biomarker levels (33).
A two-tailed p-value < 0.05 was considered to be statistically significant. All statistical analyses were performed with SAS version 9.3 (SAS Institute, Cary, NC) statistical software package.
Results
Baseline characteristics of cases and controls
Selected baseline characteristics of the colon and rectal cases and their matched controls are compared in Table 1 . Colon and rectal cancer cases were on average 58.8 years and 58.1 years old, respectively. Both colon and rectal cancer cases were more likely to be current smokers, inactive, had higher education, higher total daily energy, and consume less fruit and vegetable than their matched controls. For colon cancer, female cases had lower median concentrations of anti-flagellin-IgA (1.05 vs. 1.17), anti-LPS-IgA (1.56 vs. 1.71), and anti-LPS-IgG (1.36 vs. 1.44), collectively referred to as anti-LPS+flagellin biomarkers, than their matched controls, while the concentrations of each of these serological biomarkers were higher in cases than controls in men (anti-flagellin-IgA: 1.33 vs. 1.30; anti-LPS-IgA: 1.83 vs. 1.68; anti-LPS-IgG: 1.45 vs. 1.37). For rectal cancer, concentrations of each of the serological biomarkers were higher in cases than controls in women, except anti-LPS-IgA, where cases had lower concentrations than controls (1.38 vs. 1.48). On the other hand, concentrations of all the serological biomarkers were slightly lower in male rectal cancer 
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Associations of anti-flagellin-and anti-LPS IgA and IgG with CRC
All models found no association between CRC and biomarkers of either anti-LPS or antiflagellin ( Supplemental Table S1 ). However, when analyses were stratified by sex, a significant interaction of the CRC-LPS/flagellin risk association (total-anti-flagellin+LPS, p interaction < 0.05) was observed. Among men, there was a significant, positive association between CRC risk and levels of total-anti-flagellin+LPS exposure ( Table 2 ) with a fullyadjusted OR of 1.66 (95% CI, 1.10-2.51) comparing the higest vs. lowest quartiles, and a significant test for trend (p trend 0.049).
In contrast, among women, there were inverse associations with CRC risk. Anti-flagellin-IgA was negatively associated with risk of CRC (fully-adjusted OR = 0.65 comparing highest vs. lowest quartiles; 95% CI, 0.44-0.96; p trend = 0.02). In addition, there was a trend of significant inverse association between LPS-IgA and risk of CRC with p trend of 0.02. Unlike among men, the levels of total-anti-flagellin+LPS exposure were also negatively related to CRC risk, though the association did not reach significance (fully-adjusted OR = 0.70 comparing highest vs. lowest quartiles; 95% CI, 0.47-1.02; p trend = 0.18) .
Associations of anti-LPS and anti-flagellin concentrations with colon and rectal cancer stratified by sex
In stratified-analyses by anatomical sub-sites (p heterogenity = 0.64), colon cancer risk in men continued to be significantly positively associated with total-anti-flagellin+LPS concentrations (fully-adjusted OR = 1.80 comparing highest vs. lowest quartiles; 95% CI, 1.04-3.10; p trend < 0.049) ( Table 3) , as well as with total-anti-LPS (fully-adjusted OR = 1.97; 95% CI, 1.15-3.39; p trend = 0.01). However, among women, higher concentrations of several biomarkers remained associated with reduced risk of colon cancer with fullyadjusted ORs of 0.59 (95% CI, 0.37-0.93), 0.57 (95% CI, 0.35-0.91), and 0.62 (95% CI, 0.39-0.98), comparing those with highest quartiles of flagellin-IgA, LPS-IgG, and total-anti-LPS to reference, respectively ( Table 3 ).
No significant association was observed between risk of rectal cancer and any of the measures for either men or women (Table 4) .
Interactions with inflammation, body size, and dietary fat
The analysis of the interaction between total anti-LPS+flagellin level and inflammation (hs-CRP), body size (waist circumference and BMI), alcohol consumption, and dietary fat intake showed that, among men, the positive association between CRC risk and total anti-LPS +flagellin level was stronger at higher levels of hs-CRP 
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Sensitivity analysis
After excluding cases that occurred during the first two years of follow-up and their matched controls to avoid possible reverse causality, the findings did not change substantially for any of the serologic biomarkers in both colon and rectal cancers for either sex ( Supplemental  Table S3 ). Similar results were observed after excluding participants in the countries with lowest (Denmark) and highest (Greece) anti-LPS-and anti-flagellin biomarker exposure levels (data not shown). Spline models showed that the associations between anti-flagellin and anti-LPS biomarkers and risk of colon or rectal cancers were linear (data not shown).
Discussion
In this nested case-control study, we investigated the associations of serologic bacterial markers of LPS-and flagellin-IgA and IgG with CRC risk. No significant associations were observed with CRC risk, but sub-group analyses by sex revealed a positive association in men for LPS and flagellin markers combined, while in women the associations were inverse.
One key mechanism whereby microbiota may influence CRC development is through intestinal barrier dysfunction (34). There is an emerging recognition of the ability of the GI tract to regulate the trafficking of macromolecules between the environment and the host through a barrier mechanism (35). A growing body of evidence supports a link between increased intestinal permeability and several GI disorders such as IBD (36), which is a known risk factor for CRC. It has been suggested that some dietary / lifestyle exposures (e.g. total fat intake, body weight) and physiological factors (e.g. inflammation) may exacerbate intestinal permeability leading to increased exposure of the colonic epithelium to endotoxins and greater leakage of endotoxins into the systemic circulation (37, 38) .
The impact of bacteria on the development of CRC has been mostly studied from the perspective of inflammatory responses. It has become clear that the microbiota has a major influence on immune responses and chronic inflammation is a well-established risk factor for CRC (39) . LPS have been suggested to be involved in CRC development through their roles in stimulating the immune system by binding cell-surface Toll-like receptor (TLR)-4, the predominant receptor for LPS, and activating transcription factors, such as NF-κB, resulting in an increased production of pro-inflammatory cytokines, such as TNF-α, interleukin (IL)-1, and IL-6 (40) . Flagellin is recognized by both TLR-5, and the NLRC4 inflammasome, which elicits immune signals by activation of NF-κB and caspase-1 respectively, and hence promotes systemic inflammation by production of multiple inflammatory cytokines (41, 42) .
Despite a growing body of evidence from in vitro and in vivo studies on the role of the microbiome in the development of CRC, limited epidemiological studies have thus far been available to show associations between bacterial endotoxin exposure and colorectal adenomas or CRC. Two recent studies have observed a positive relationship between endotoxin and colorectal adenomas (43, 44) with the strongest associations observed for dysplastic lesions (44) . Our results showing a positive association of serum LPS and flagellin biomarkers and CRC in men are in line with the results of these studies on the role of bacteria exposure in CRC carcinogenesis. However, these studies did not report sex stratified findings so do not permit compassion with our findings in women.
We observed in hypothesis generating analyses that the positive associations between LPS and flagellin levels and risk of CRC in men were stronger in higher levels of hs-CRP, waist circumference, and BMI, results which, if replicated, suggest that these factors may play a role in exacerbating the CRC promotive effects of LPS and flagellin. Also worthy of examination is the possibility that body size and inflammation may influence intestinal permeability and so lead to increased exposure to bacterial products.
Based on the observations from the above mentioned studies, an inverse association between LPS and flagellin levels and CRC risk that we observed among women was unexpected. However, other studies have previously demonstrated inverse associations between environmental endotoxin exposures and the risk of lung and other cancers in occupational settings. Protective effects of environmental/occupational endotoxin exposure on lung cancer have been consistently demonstrated in studies of cotton textile due to raw cotton fibre or dust being contaminated with bacterial endotoxin (45) (46) (47) and farming industries (48), protection hypothesized to result from potential anti-carcinogenic effects of endotoxin mediated by the innate and acquired immune systems (47) . Differences between men and women have also been observed among cotton plant workers where there was an increased risk of colon and liver cancers in men while women had lower risk of rectal/anal and liver cancers (49) . However, these previous studies were based on occupational cohorts with high endotoxin exposures while the endotoxin measures of our study subjects are likely to be derived largely from the colonic bacteria rather than the environment. Therefore, careful interpretation is required when comparing our findings to those of previous studies looking at specific subject groups.
Two mechanisms may be involved in the differences between men and women which we observed in the associations between endotoxin and risk of CRC. First, complex interaction between the innate and adaptive immune systems are important underlying mechanisms of associations between endotoxin and carcinogenesis (50) . The differences between men and women are observed could therefore result from well-established sex-based differences in the immune systems that result in women having a more vigorous immune response, both cellular and humoral, than men (51-53). Second, it is possible that the composition of microbiota could differ in men and women as sex differences have been observed in the composition of skin microbiota (54) . It is therefore possible that different organisms might have different associations with colon carcinogenesis and so account for the differences between men and women we observed. Such possibilities have yet to be studied in detail.
Lastly, it is possible that our gender-specific observations are due to chance, despite the relatively large size of the present study. Therefore, replication of these findings and deeper exploration of the sex-specific bacterial exposure and CRC hypothesis is required.
The present study has several strengths. Our study is the largest prospective cohort so far to investigate bacterial exposures and CRC risk. Therefore, we had a large enough sample size to be able to stratify by anatomical sub-sites of CRC and by gender. To our knowledge, no previous studies on bacterial exposure and CRC risk have had a sufficiently large enough sample size to conduct stratified analyses.
We also have several limitations in the study. First, since the gut is colonized by complex bacterial communities, elevated LPS or flagellin levels alone may not be sufficient to promote inflammation and tumour progression (43) . Also, we were only able to measure IgA and IgG for either LPS or flagellin in our study, but not any other antibody isotypes.
Another limitation is that we measured the LPS and flagellin concentrations in serum, not in the colonic mucosa, which could be more relevant for colorectal carcinoma formation. Indeed, the assay we applied measures serum immunoreactivity to common bacterial flagellin monomers, which have highly conserved regions common to many flagellins in the microbiota. Although differences in such flagellin immunoreactivity have been thought to reflect differences in gut permeability, they may also arise from differences in microbiota composition and/or gene expression. Thus, better clarification of the source and biological properties of these compounds is a task for future research. Moreover, bio-samples were available from only from the time of recruitment into the cohort and thus we only had a single blood measure taken at one point in time.
In summary, we found no overall association between bacterial exposure levels, measured by LPS-and flagellin-IgA and IgG, and risk of CRC. However, in sub-group analysis by sex, we found some biomarker levels to be positively associated with CRC risk among men while they were inversely associated with CRC risk among women. Further studies are warranted to elucidate the underlying mechanisms of bacterial exposure and CRC by sex as well as the sex-specific role of inflammation and immune response on CRC risk.
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